Company / Assets per Share
Supernus Pharmaceuticals, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$26.06
FY2025
5-year range
$23.02 / $31.97
FY2021-FY2025
Trend
+4.2%
vs FY2024
Sector context
#47 of 210
Health Care
What the data says
Supernus Pharmaceuticals, Inc.'s assets per share of $26.06 is higher than 78% of companies in the Health Care sector (FY2025). Improved from $23.02 to $26.06 over the past 2 years.
Based on SEC 10-K filings.
26.06 in FY2025 with a 5-year CAGR of -1.9%. Top quartile in the Health Care sector.
Improved from $23.02 to $26.06 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -6.6%
- 5-Year CAGR
- -1.9%
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 210This company $26.06 Sector average $353.15
▼
-92.6% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 4.2% year-over-year.
- Ranks #47 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2022.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.06 | +4.2% |
| FY2024 | $25.00 | +8.6% |
| FY2023 | $23.02 | -28.0% |
| FY2022 | $31.97 | +0.1% |
| FY2021 | $31.95 | +11.6% |
| FY2020 | $28.63 | +29.1% |
| FY2019 | $22.18 | +16.4% |
| FY2018 | $19.06 | +124.3% |
| FY2017 | $8.49 | +34.5% |
| FY2016 | $6.32 | +43.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026